ProMIS Neurosciences Inc. (ARFXF)

Advancing Novel Antibody Therapeutics for Neurodegenerative Diseases

April 20, 2020
Report ID: 11389
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


ProMIS Neurosciences Inc.
ProMIS Neurosciences Inc.
Healthcare
Biotechnology
Ticker
ARFXF
Current Price
$0.102
Market Cap
$875.1K
Price Target
Refer to Report
52wk Range
$ - $
Related Research Reports
4/20/2020

Advancing Novel Antibody Therapeutics for Neurodegenerative Diseases
Advancing Novel Antibody Therapeutics for Neurodegenerative Diseases (ARFXF)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.